A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy
Clinical trial NCT00673920 · TERMINATED
Trial details
- NCT number
- NCT00673920
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-24
- Primary completion
- 2009-10-26
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.